Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung cancer
Pharma
Boehringer touts promising launches of Hernexeos, Jascayd
Without reporting sales figures, Boehringer Ingelheim touted its promising launches of lung disease drug Jascayd and lung cancer therapy Hernexeos.
Kevin Dunleavy
Mar 25, 2026 10:57am
Gilead inks Manta pact to dive deeper into cancer patient aid
Mar 24, 2026 10:50am
J&J alleges trade secret theft by former staffer linked to Summit
Mar 16, 2026 10:44am
AZ, Daiichi's Datroway scores overall survival win in TNBC
Oct 6, 2025 10:48am
Guardant backs ALA's lung cancer testing awareness drive
Sep 25, 2025 9:45am
Editor's Corner—Summit must submit to Big Pharma, stat
Sep 10, 2025 2:50pm
